Related Experiment Videos
Enkephalin antisense peptides: design, synthesis, and biological activity
1Division of Biopolymers, Central Drug Research Institute, Lucknow, India.
Pharmaceutical Research
|May 1, 1993
Summary
Antisense peptides derived from Metenkephalin mRNA, including compound 88/62 and its analogue 88/63, demonstrate synergistic effects on opioid activity. These findings reveal novel interactions within the opioid system.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Metenkephalin is a key endogenous opioid peptide involved in pain modulation and reward pathways.
- Antisense mRNA technology offers a novel approach to modulate gene and protein expression.
Purpose of the Study:
- To investigate the opioid activity of antisense peptides derived from Metenkephalin.
- To explore the synergistic effects of these peptides on Metenkephalin's opioid function.
Main Methods:
- Synthesis and characterization of antisense peptides, including His-Glu-Ala-Pro-Ile (compound 88/62) and its (Gln1)-analogue (compound 88/63).
- Assessment of opioid activity using the guinea pig ileum (GPI) test system.
Main Results:
- The antisense peptide (compound 88/62) exhibited opioid activity.
- Compound 88/62 and its (Gln1)-analogue (compound 88/63) displayed synergistic effects on Metenkephalin's opioid activity in the GPI test system.
Conclusions:
- Antisense peptides derived from Metenkephalin can modulate opioid activity.
- The synergistic interaction between antisense peptides and Metenkephalin suggests novel regulatory mechanisms in the opioid system.